Mylan Laboratories, Inc. (MYL)
$17.55
0.12 (+0.69%)
| CAPS Rating |
|
|---|---|
| Open | $17.44 |
| Previous Close | $17.43 |
| Daily Range | $17.31 - $17.63 |
| 52-Week Range | $7.09 - $18.10 |
| Market Cap | $5.36B |
| P/E Ratio | 108.94 |
| Dividend (Yield) | 0.24 (1.20%) |
| Volume | 4,093,232 |
| Average Daily Volume | 7,212,000 |
MYL
VS S&P 500 (SPY)
How do you think MYL will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
MYL Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
MYL News and Commentary
- Pfizer's Generic Growth, With a Side of Sashimi – The Motley Fool
- The Life-and-Death Situation That Isn't – The Motley Fool
- Nice Quarter, Teva. What Will You Buy Next? – The Motley Fool
- Fox Business on Mylan, Inc. – Ockham-RazorWire
- Fox Business on Mylan, Inc. – Ockham-RazorWire
- UPDATE 1-Mylan posts net loss, but results top views – Reuters
- Dream Stocks for Contrarian Investors – The Motley Fool
- Small Market, Small Acquisition, Still a Good Move – The Motley Fool
- 5-Star Stocks Poised to Pop: Teva – The Motley Fool
- US says drugmakers to pay $124 mln in settlement – Reuters
- UPDATE 1-Mylan settles Medicaid dispute,to pay $121 million – Reuters
- UPDATE 1-Mylan to sell generic of Pfizer antifungal drug – Reuters
- A Big Upgrade for Teva Pharmaceutical – The Motley Fool
- Magic Formula Stocks by Relative Strength – Blog at The Motley Fool
- Bigger Size, Lower Returns – The Motley Fool
- Will Teva Be Forced to Take Its Own Medicine? – The Motley Fool
- 5 Stocks Making Cash – The Motley Fool
- Magic Formula Weekly Roundup 8/30 – Blog at The Motley Fool
- The Cash Cow Is Out of Milk – The Motley Fool
- Two Pictures of a Drug Company – The Motley Fool
RSS Headlines
Fool UK
